Pier Capital, LLC
- SEC CIK
- 0001310051
- Latest filing
- Aug 5, 2026
DNLI holding history
Denali Therapeutics Inc. in every 13F filed by Pier Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −301,171−100.0% | Sold out | Holders |
| Q3 2025 | 301,171 | $4.37M | 0.7% | −13,625−4.3% | Reduced | Holders |
| Q2 2025 | 314,796 | $4.40M | 0.7% | −20,708−6.2% | Reduced | Holders |
| Q1 2025 | 335,504 | $4.56M | 0.8% | +3,185+1.0% | Added | Holders |
| Q4 2024 | 332,319 | $6.77M | 1.0% | +164,237+97.7% | Added | Holders |
| Q3 2024 | 168,082 | $4.90M | 0.7% | +2,596+1.6% | Added | Holders |
| Q2 2024 | 165,486 | $3.84M | 0.6% | −6,845−4.0% | Reduced | Holders |
| Q1 2024 | 172,331 | $3.54M | 0.5% | −1,888−1.1% | Reduced | Holders |
| Q4 2023 | 174,219 | $3.74M | 0.5% | +49,139+39.3% | Added | Holders |
| Q3 2023 | 125,080 | $2.58M | 0.4% | −2,048−1.6% | Reduced | Holders |
| Q2 2023 | 127,128 | $3.75M | 0.5% | +127,128 | New | Holders |